Latanoprost is 'n nuwe feniel-gesubstitueerde propylester prostaglandien F2a, wat 'n selektiewe F2a-reseptoragonis is. Dit is 'n onaktiewe stof wat vinnig in die kornea kan binnedring. Dit kan gehidroliseer word in aktiewe vrye sure in kornea en plasma. Dit kan die uitvloei van waterige humor deur die canthus-laag verhoog. Die dosis is klein, maar dit kan die vul van waterige humor bevorder. Die vloeibare medisyne kan in die boonste laag van siliêre choroid op die oogbal binnedring, en het 'n goeie effek om intraokulêre druk te verminder.
Latanoprost ophthalmic solution is a medication administered into the eyes to control the progression of glaucoma or ocular hypertension by reducing intraocular pressure. It is a prostaglandin analogue (more specifically an analogue of prostaglandin F2α) that lowers the pressure by increasing the outflow of aqueous fluid from the eyes through the uvealsclearal tract. Latanoprost is an isopropyl ester prodrug, meaning it is inactive until it is hydrolyzed by esterases in the cornea to the biologically active acid.
